Evidence map›Paper›PMID 31545911›Full record

ArticlePharmaceutical biology2019

Preliminary safety assessment of oridonin in zebrafish.

Lili Tian, Donglai Sheng, Qiushuang Li, Chenxu Guo, Guofu Zhu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutical biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Oridonin fromFood science & nutrition · 2024
    Review
  2. Oridonin InhibitsPathogens (Basel, Switzerland) · 2023
    Article
  3. Chalcone: A potential scaffold for NLRP3 inflammasome inhibitors.European journal of medicinal chemistry reports · 2023
    Article
  4. Review
  5. Roots and stems ofPharmaceutical biology · 2020
    Article
  6. Diterpenoids fromRSC advances · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 1 country.

Lili TianSchool of Pharmacy, Shanghai University of Traditional Chinese Medicine , Shanghai , China.
Donglai ShengInstitute of Developmental and Regenerative Biology, Hangzhou Normal University , Hangzhou , China.
Qiushuang LiCenter of Clinical Evaluation and Analysis, Zhejiang Provincial Hospital of Traditional Chinese Medicine , Hangzhou , China.
Chenxu GuoDepartment of Integrated Chinese and Western Medicine, Shanghai Eastern Hepatobiliary Surgery Hospital , Shanghai , China.
Guofu ZhuSchool of Pharmacy, Shanghai University of Traditional Chinese Medicine , Shanghai , China.
Hangzhou Hospital of Traditional Chinese Medicine · CNHangzhou Normal University · CNSecond Military Medical University · CNShanghai University of Traditional Chinese Medicine · CNZhejiang Provincial Hospital of TCM · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAntineoplastic AgentsDiterpenes, KauraneGene Expression Regulation, DevelopmentalGrowth and DevelopmentHeart RateLarvaSwimmingVascular Endothelial Growth FactorsZebrafishAntineoplastic AgentsDiterpenes, KauraneoridoninVascular Endothelial Growth Factorsbody lengthembryonic development effectsmedicinal plantswimming speedVEGFR3

Identifiers

PMID31545911
PMCPMC6764400
OpenAlexW2976409794

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.